Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BDR
7126
DELISTED
Blonder Tongue Laboratories Inc
BDR
| $17K | ﹤0.01% |
+29,823
| New | +$20.1K |
2017 Q1
0 quarters
|
|
|
UQM
7127
DELISTED
UQM Technologies, Inc.
UQM
| $17K | ﹤0.01% |
34,497
+5,948
| +21% | +$2.8K |
2016 Q1
4 quarters
|
|
|
NAVB
7128
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $17K | ﹤0.01% |
+1,470
| New | +$16.7K |
2017 Q1
0 quarters
|
|
|
BSTG
7129
DELISTED
Biostage, Inc. Common Stock
BSTG
| $17K | ﹤0.01% |
+45,460
| New | +$24.9K |
2017 Q1
0 quarters
|
|
|
UNXL
7130
CALL
DELISTED
Uni-Pixel, Inc.
UNXL
| $17K | ﹤0.01% |
20,100
-13,100
| -39% | -$14.5K |
2013 Q2
15 quarters
|
|
|
ORIG
7131
PUT
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $17K | ﹤0.01% |
7
-3
| -30% | -$31.1K |
2014 Q3
10 quarters
|
|
7132
CareCloud
CCLD
$85.8M
| $16K | ﹤0.01% |
+23,694
| New | +$17.2K |
2017 Q1
0 quarters
|
|
7133
CEL-SCI Corp
CVM
$40.6M
| $16K | ﹤0.01% |
+242
| New | +$19.3K |
2017 Q1
0 quarters
|
|
|
DRRX
7134
PUT
DELISTED
DURECT Corp
DRRX
| $16K | ﹤0.01% |
1,490
-1,520
| -50% | -$16.3K |
2016 Q3
2 quarters
|
|
7135
Solitario Resources
XPL
$54.3M
| $16K | ﹤0.01% |
+19,892
| New | +$15.1K |
2017 Q1
0 quarters
|
|
|
BIMI
7136
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
| $16K | ﹤0.01% |
284
-107
| -27% | -$5.54K |
2016 Q2
3 quarters
|
|
|
AMPE
7137
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $16K | ﹤0.01% |
+66
| New | +$17.7K |
2017 Q1
0 quarters
|
|
|
SCON
7138
DELISTED
Superconductor Technologies Inc.
SCON
| $16K | ﹤0.01% |
+125
| New | +$14.9K |
2017 Q1
0 quarters
|
|
|
SDT
7139
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
| $16K | ﹤0.01% |
11,390
-31,820
| -74% | -$48.1K |
2016 Q2
3 quarters
|
|
|
BONT
7140
CALL
DELISTED
Bon-Ton Stores Inc/The
BONT
| $16K | ﹤0.01% |
+19,500
| New | +$22.1K |
2017 Q1
0 quarters
|
|
|
CBR
7141
DELISTED
CIBER Inc.
CBR
| $16K | ﹤0.01% |
+39,879
| New | +$18K |
2017 Q1
0 quarters
|
|
7142
Taoping
TAOP
$3.9M
| $15K | ﹤0.01% |
+12
| New | +$16.7K |
2017 Q1
0 quarters
|
|
7143
US Gold Corp
USAU
$239M
| $15K | ﹤0.01% |
322
+2
| +0.6% | +$112 |
2016 Q4
1 quarter
|
|
|
AIFC
7144
AI Financial Corp
AIFC
$70.4M
| $15K | ﹤0.01% |
+2,775
| New | +$15.4K |
2017 Q1
0 quarters
|
|
|
AAU
7145
CALL
DELISTED
Almaden Minerals Ltd
AAU
| $15K | ﹤0.01% |
+12,500
| New | +$13.6K |
2017 Q1
0 quarters
|
|
|
TMBR
7146
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $15K | ﹤0.01% |
+2
| New | +$13.8K |
2017 Q1
0 quarters
|
|
|
PPP
7147
DELISTED
Primero Mining Corp
PPP
| $15K | ﹤0.01% |
27,927
-649
| -2% | -$457 |
2014 Q2
11 quarters
|
|
|
WINT
7148
CALL
DELISTED
Windtree Therapeutics Inc
WINT
| $15K | ﹤0.01% |
+13,100
| New | +$17K |
2017 Q1
0 quarters
|
|
|
IKGH
7149
DELISTED
Iao Kun Group Holding Company Limited
IKGH
| $15K | ﹤0.01% |
48,939
-8,326
| -15% | -$2.57K |
2016 Q3
2 quarters
|
|
|
COYN
7150
DELISTED
COPsync, Inc.
COYN
| $15K | ﹤0.01% |
50,612
+34,323
| +211% | +$15.9K |
2016 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.